Annual EBITDA
-$133.48 M
-$33.46 M-33.45%
December 31, 2023
Summary
- As of February 8, 2025, ETNB annual EBITDA is -$133.48 million, with the most recent change of -$33.46 million (-33.45%) on December 31, 2023.
- During the last 3 years, ETNB annual EBITDA has fallen by -$84.18 million (-170.77%).
- ETNB annual EBITDA is now -780.69% below its all-time high of -$15.16 million, reached on December 31, 2018.
Performance
ETNB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$146.50 M
-$99.55 M-212.03%
September 30, 2024
Summary
- As of February 8, 2025, ETNB quarterly EBITDA is -$146.50 million, with the most recent change of -$99.55 million (-212.03%) on September 30, 2024.
- Over the past year, ETNB quarterly EBITDA has dropped by -$112.74 million (-333.99%).
- ETNB quarterly EBITDA is now -3769.49% below its all-time high of -$3.79 million, reached on September 30, 2018.
Performance
ETNB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$279.65 M
-$112.74 M-67.55%
September 30, 2024
Summary
- As of February 8, 2025, ETNB TTM EBITDA is -$279.65 million, with the most recent change of -$112.74 million (-67.55%) on September 30, 2024.
- Over the past year, ETNB TTM EBITDA has dropped by -$157.63 million (-129.19%).
- ETNB TTM EBITDA is now -7286.37% below its all-time high of -$3.79 million, reached on September 30, 2018.
Performance
ETNB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ETNB EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.5% | -334.0% | -129.2% |
| 3 y3 years | -170.8% | -509.8% | -179.7% |
| 5 y5 years | -780.7% | -509.8% | -179.7% |
ETNB EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -49.1% | at low | -509.8% | at low | -212.4% | at low |
| 5 y | 5-year | -401.4% | at low | -1425.1% | at low | -950.4% | at low |
| alltime | all time | -780.7% | at low | -3769.5% | at low | -7286.4% | at low |
89bio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$146.50 M(+212.0%) | -$279.65 M(+67.5%) |
| Jun 2024 | - | -$46.95 M(-7.4%) | -$166.91 M(+6.0%) |
| Mar 2024 | - | -$50.71 M(+42.9%) | -$157.44 M(+18.0%) |
| Dec 2023 | -$133.48 M(+33.5%) | -$35.49 M(+5.1%) | -$133.48 M(+9.4%) |
| Sep 2023 | - | -$33.76 M(-10.0%) | -$122.02 M(+6.6%) |
| Jun 2023 | - | -$37.49 M(+40.2%) | -$114.51 M(+12.7%) |
| Mar 2023 | - | -$26.75 M(+11.3%) | -$101.63 M(+1.7%) |
| Dec 2022 | -$100.02 M(+11.7%) | -$24.03 M(-8.5%) | -$99.97 M(-2.0%) |
| Sep 2022 | - | -$26.25 M(+6.7%) | -$102.02 M(-1.9%) |
| Jun 2022 | - | -$24.60 M(-1.9%) | -$103.95 M(+4.1%) |
| Mar 2022 | - | -$25.09 M(-3.8%) | -$99.88 M(+11.6%) |
| Dec 2021 | -$89.52 M | -$26.07 M(-7.5%) | -$89.52 M(+17.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$28.19 M(+37.3%) | -$75.98 M(+22.1%) |
| Jun 2021 | - | -$20.53 M(+39.4%) | -$62.20 M(+16.6%) |
| Mar 2021 | - | -$14.72 M(+17.5%) | -$53.33 M(+8.2%) |
| Dec 2020 | -$49.30 M(+85.2%) | -$12.53 M(-13.0%) | -$49.30 M(+6.3%) |
| Sep 2020 | - | -$14.41 M(+23.7%) | -$46.37 M(+15.5%) |
| Jun 2020 | - | -$11.66 M(+9.0%) | -$40.15 M(+23.6%) |
| Mar 2020 | - | -$10.69 M(+11.3%) | -$32.48 M(+22.0%) |
| Dec 2019 | -$26.62 M(+75.7%) | -$9.61 M(+17.2%) | -$26.62 M(+24.3%) |
| Sep 2019 | - | -$8.19 M(+105.1%) | -$21.42 M(+25.9%) |
| Jun 2019 | - | -$4.00 M(-17.3%) | -$17.02 M(+30.7%) |
| Mar 2019 | - | -$4.83 M(+9.6%) | -$13.02 M(+58.9%) |
| Dec 2018 | -$15.16 M | -$4.41 M(+16.4%) | -$8.19 M(+116.4%) |
| Sep 2018 | - | -$3.79 M | -$3.79 M |
FAQ
- What is 89bio annual EBITDA?
- What is the all time high annual EBITDA for 89bio?
- What is 89bio annual EBITDA year-on-year change?
- What is 89bio quarterly EBITDA?
- What is the all time high quarterly EBITDA for 89bio?
- What is 89bio quarterly EBITDA year-on-year change?
- What is 89bio TTM EBITDA?
- What is the all time high TTM EBITDA for 89bio?
- What is 89bio TTM EBITDA year-on-year change?
What is 89bio annual EBITDA?
The current annual EBITDA of ETNB is -$133.48 M
What is the all time high annual EBITDA for 89bio?
89bio all-time high annual EBITDA is -$15.16 M
What is 89bio annual EBITDA year-on-year change?
Over the past year, ETNB annual EBITDA has changed by -$33.46 M (-33.45%)
What is 89bio quarterly EBITDA?
The current quarterly EBITDA of ETNB is -$146.50 M
What is the all time high quarterly EBITDA for 89bio?
89bio all-time high quarterly EBITDA is -$3.79 M
What is 89bio quarterly EBITDA year-on-year change?
Over the past year, ETNB quarterly EBITDA has changed by -$112.74 M (-333.99%)
What is 89bio TTM EBITDA?
The current TTM EBITDA of ETNB is -$279.65 M
What is the all time high TTM EBITDA for 89bio?
89bio all-time high TTM EBITDA is -$3.79 M
What is 89bio TTM EBITDA year-on-year change?
Over the past year, ETNB TTM EBITDA has changed by -$157.63 M (-129.19%)